Carbon dioxide laser ablation combined with doxorubicin hydrochloride treatment for vaginal fibrosarcoma in a dog

J Am Vet Med Assoc. 1992 Jul 1;201(1):109-10.

Abstract

The combined use of CO2 laser ablation and doxorubicin hydrochloride (30 mg/m2) administered twice, 4 weeks apart, resulted in complete remission of vaginal fibrosarcoma in a 10-year-old Miniature Poodle. The tumor had redeveloped when only CO2 ablation was used for treatment and doxorubicin hydrochloride alone has had marginal influence on fibrosarcomas; however, use of both treatments in this dog resulted in a 20-month, disease-free period. This treatment combination was minimally traumatic to the dog, easily accomplished, and effective, and it allowed retention of the normal anatomy and function of the urogenital tract.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Chemotherapy, Adjuvant
  • Colposcopy / veterinary
  • Dog Diseases / drug therapy
  • Dog Diseases / surgery*
  • Dogs
  • Doxorubicin / therapeutic use*
  • Female
  • Fibrosarcoma / drug therapy
  • Fibrosarcoma / surgery
  • Fibrosarcoma / veterinary*
  • Laser Therapy / veterinary*
  • Vaginal Neoplasms / drug therapy
  • Vaginal Neoplasms / surgery
  • Vaginal Neoplasms / veterinary*

Substances

  • Doxorubicin